Having trouble accessing articles? Reset your cache.

Neon improves predictions for CD4-stimulating tumor antigens

In the latest step toward breaking the barrier to identifying neoantigens displayed on MHCII, Neon has generated a systems biology model that outperforms publicly available predictors.

The development brings immuno-oncology closer to personalized therapies directing CD4+ T cells against tumor neoantigens.

A growing number

Read the full 421 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE